President and CEO of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), Watanabe Todd Franklin, sells 1,500 shares worth $52,500
According to Arcutis Biotherapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated May 04 03:00 PM, company President and CEO, Watanabe Todd Franklin disclosed selling 1,500 shares at a cost of $35.00. At the time of this transaction (Apr 30), this trade was worth $52,500 in total. As of Apr 30, Watanabe Todd Franklin now owns 593,916 shares in total worth about $19,931,820.96.
For the last few recent trades made by Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) President and CEO, Watanabe Todd Franklin, we have the following information:
- SEC Form 4 filing: Apr 05: Sold 1,750 shares at the rate of $29.93 per share. Total worth of this trade was $52,378. Total number of shares owned as of Apr 05 were 595,416
- SEC Form 4 filing: Mar 05: Sold 1,750 shares at the rate of $30.55 per share. Total worth of this trade was $53,462. Total number of shares owned as of Mar 05 were 597,166
- SEC Form 4 filing: Mar 02: Sold 2,107 shares at the rate of $35.19 per share. Total worth of this trade was $74,136. Total number of shares owned as of Mar 02 were 566,216
Posted by
George Daniels
on Tuesday May 04 2021, 3:16 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
